BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27013717)

  • 1. CANCER. The oncogene makes its escape.
    Wala J; Beroukhim R
    Science; 2016 Mar; 351(6280):1398-9. PubMed ID: 27013717
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of proto-oncogenes by disruption of chromosome neighborhoods.
    Hnisz D; Weintraub AS; Day DS; Valton AL; Bak RO; Li CH; Goldmann J; Lajoie BR; Fan ZP; Sigova AA; Reddy J; Borges-Rivera D; Lee TI; Jaenisch R; Porteus MH; Dekker J; Young RA
    Science; 2016 Mar; 351(6280):1454-1458. PubMed ID: 26940867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New genetic abnormalities and treatment response in acute lymphoblastic leukemia.
    Meijerink JP; den Boer ML; Pieters R
    Semin Hematol; 2009 Jan; 46(1):16-23. PubMed ID: 19100364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic instability and tumor development.
    Nowell PC
    Basic Life Sci; 1991; 57():221-8; discussion 228-31. PubMed ID: 1814285
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of protooncogenes and cytokine genes in acute lymphoblastic leukemia.
    Tesch H; Jücker M; Abts H; Laumann R; Ludwig WD; Pahl I
    Recent Results Cancer Res; 1993; 131():239-47. PubMed ID: 8210643
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel translocation t(1;5)(p32;q31) that was not associated with the TAL1 rearrangement in a case of T lymphoblastic leukemia/lymphoma.
    Cho HS; Kim MK; Bae YK
    Korean J Lab Med; 2009 Jun; 29(3):199-203. PubMed ID: 19571616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Alterations of Non-Coding Regions Underlie Human Cancer: Lessons from T-ALL.
    Rivera-Reyes A; Hayer KE; Bassing CH
    Trends Mol Med; 2016 Dec; 22(12):1035-1046. PubMed ID: 28240214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A second NOTCH1 chromosome rearrangement: t(9;14)(q34.3;q11.2) in T-cell neoplasia.
    Suzuki S; Nagel S; Schneider B; Chen S; Kaufmann M; Uozumi K; Arima N; Drexler HG; MacLeod RA
    Leukemia; 2009 May; 23(5):1003-6. PubMed ID: 19151773
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of proto-oncogenes in normal hemopoiesis and the genesis of leukosis].
    Blinov MN
    Eksp Onkol; 1990; 12(2):3-10. PubMed ID: 2180676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent activation of c-myc and inactivation of bcl-2 by chromosomal translocation in a lymphoblastic lymphoma cell line.
    Kiem HP; Nourse J; Saltman DL; Blume KG; Cleary ML
    Oncogene; 1990 Dec; 5(12):1815-9. PubMed ID: 2284100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deciphering functional activity of TLX homeodomain oncogenes in T-ALL: a clue for a differentiating therapy?].
    Asnafi V; Ferrier P
    Med Sci (Paris); 2012; 28(8-9):708-10. PubMed ID: 22920872
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chromosome aberrations as a prognostic factor in children with acute lymphoblastic leukemia].
    Kubiczek K; Rytlewska M
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):369-72. PubMed ID: 1437756
    [No Abstract]   [Full Text] [Related]  

  • 14. High frequency of cryptic chromosomal rearrangements involving the LMO2 gene in T-cell acute lymphoblastic leukemia.
    Wu L; Xu Y; Wang Q; Ruan C; Drexler HG; Wu D; MacLeod RA; Chen S
    Haematologica; 2015 Jun; 100(6):e233-6. PubMed ID: 25682596
    [No Abstract]   [Full Text] [Related]  

  • 15. BCL-2 gene rearrangements in lymphoid malignancies.
    Crisan D
    Clin Lab Med; 1996 Mar; 16(1):23-47. PubMed ID: 8867581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correct interpretation of T-ALL oncogene expression relies on normal human thymocyte subsets as reference material.
    Larmonie NS; Dik WA; van der Velden VH; Hoogeveen PG; Beverloo HB; Meijerink JP; van Dongen JJ; Langerak AW
    Br J Haematol; 2012 Apr; 157(1):142-6. PubMed ID: 22053714
    [No Abstract]   [Full Text] [Related]  

  • 17. The c-ets-1 proto-oncogene is rearranged in some cases of acute lymphoblastic leukaemia.
    Goyns MH; Hann IM; Stewart J; Gegonne A; Birnie GD
    Br J Cancer; 1987 Nov; 56(5):611-3. PubMed ID: 3480753
    [No Abstract]   [Full Text] [Related]  

  • 18. TRIB2 reinforces the oncogenic transcriptional program controlled by the TAL1 complex in T-cell acute lymphoblastic leukemia.
    Tan SH; Yam AW; Lawton LN; Wong RW; Young RA; Look AT; Sanda T
    Leukemia; 2016 Apr; 30(4):959-62. PubMed ID: 26202930
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of c-kit proto-oncogene rearrangement in patients with acute lymphoblastic leukemia (ALL) and the t(4;11)(q21;q23) translocation.
    Schardt C; Stadler M; Hoelzer D; Ganser A
    Leukemia; 1992 Oct; 6(10):1079-80. PubMed ID: 1383648
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular correlates of cytogenetic abnormalities in human cancer cells: implications for oncogene activation.
    Brodeur GM
    Prog Hematol; 1986; 14():229-56. PubMed ID: 3003796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.